Research Tracker›Biomarker Atlas›Marker Pages›Spike in neurological tissue

Spike in neurological tissue: biomarker evidence

Spike in neurological tissue appears in 1 entry of the OSMF biomarker atlas, covering PACVS. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

PACVS

Where Spike in neurological tissue is reported

Also listed as: Post-vaccine neurological AE

ConditionDirectionCompared againstAssociated symptomsSource
PACVS↑ elevatedhealthy controlsNeurological complicationsOta et al. 2025

Frequently asked questions

In which conditions is Spike in neurological tissue altered?

In the OSMF atlas Spike in neurological tissue is reported in PACVS. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Spike in neurological tissue?

The atlas entries for Spike in neurological tissue do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Spike in neurological tissue result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Spike in neurological tissue across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/spike-in-neurological-tissue.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.